Search for: "ARIAD PHARMACEUTICAL V ELI LILLY"
Results 61 - 80
of 91
Sorted by Relevance
|
Sort by Date
17 Apr 2009, 12:00 am
Eli Lilly invalid (Patent Baristas), (Law 360) (Patent Docs) Gleevec / Glivec (Imatinib) – Novartis alpha crystalline form patent invalidated at pre – grant opposition (PatentCircle) Levaquin (Levofloxacin) - Daiichi Sankyo Co. [read post]
1 Apr 2010, 3:04 am
Eli Lilly (EPLAW) [read post]
1 Apr 2013, 9:11 pm
Cir. 1996) Ariad Pharmaceuticals, Inc. v. [read post]
26 Aug 2009, 6:12 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Nexavar (Sorafenib) – India: Delhi High Court rejects Bayer complaint for patent linkage (Intellectual Property Watch) (Spicy IP) (GenericsWeb) Evista / Xigris - US: CAFC grants en banc request to challenge written description requirement: Ariad v Lilly (Patently-O) (Filewrapper) (Washington State Patent Law… [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description:… [read post]
20 Sep 2016, 11:12 am
” Ariad Pharmaceuticals, Inc. v. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
25 Nov 2009, 12:00 pm
Maharaja Appliances (Spicy IP) India: Harmonising the interpretation of ‘efficacy’ in section 3(d) with Article 27 of TRIPS – IPAB decision in Glivec case (Spicy IP) UK: Medeva pertussis vaccines fail the Art 3 test as question of appeal remains unresolved: Medeva BV’s application (The SPC Blog) US: Amicus briefs in Ariad v Eli Lilly (Patent Docs) (Patent Docs) (Patent Docs) (Patent Docs) US: Senate set to debate merged health care reform… [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of… [read post]
13 Apr 2010, 10:26 am
See generally Ariad Pharmaceuticals, Inc. v. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Evista (Raloxifene) – US: Patent infringement complaint following a Paragraph IV certification: Eli Lilly & Company v. [read post]
18 Apr 2017, 6:52 am
Eli Lilly & Co., 598 F.3d 1336, 1352-53 (Fed. [read post]
30 Nov 2021, 9:36 am
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
1 Apr 2011, 5:17 pm
In Ariad Pharmaceuticals, Inc. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
